Assembly Biosciences, Inc. (ASMB)
Chart for ASMB
Over the next 13 weeks, Assembly Biosciences, Inc. has on average historically fallen by 4.8% based on the past 6 years of stock performance.
Assembly Biosciences, Inc. has fallen lower by an average 4.8% in 5 of those 6 years over the subsequent 13 week period,corresponding to a historical probability of 83%
The holding period that leads to the greatest annualized return for Assembly Biosciences, Inc., based on historical prices, is 27 weeks. Should Assembly Biosciences, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 67% could result.
Criteo S.A. (CRTO)
Chart for CRTO
Over the next 13 weeks, Criteo S.A. has on average historically risen by 8% based on the past 3 years of stock performance.
Criteo S.A. has risen higher by an average 8% in 3 of those 3 years over the subsequent 13 week period,corresponding to a historical probability of 100%
The holding period that leads to the greatest annualized return for Criteo S.A., based on historical prices, is 1 week. Should Criteo S.A. stock move in the future similarly to its average historical movement over this duration, an annualized return of 84% could result.
Dr. Reddy’s Laboratories Ltd. (RDY)
Chart for RDY
Over the next 13 weeks, Dr. Reddy’s Laboratories Ltd. has on average historically risen by 5% based on the past 16 years of stock performance.
Dr. Reddy’s Laboratories Ltd. has risen higher by an average 5% in 10 of those 16 years over the subsequent 13 week period,corresponding to a historical probability of 62%
The holding period that leads to the greatest annualized return for Dr. Reddy’s Laboratories Ltd., based on historical prices, is 1 week. Should Dr. Reddy’s Laboratories Ltd. stock move in the future similarly to its average historical movement over this duration, an annualized return of 42% could result.
Supernus Pharmaceuticals, Inc. (SUPN)
Chart for SUPN
Over the next 13 weeks, Supernus Pharmaceuticals, Inc. has on average historically fallen by 11.7% based on the past 5 years of stock performance.
Supernus Pharmaceuticals, Inc. has fallen lower by an average 11.7% in 2 of those 5 years over the subsequent 13 week period,corresponding to a historical probability of 40%
The holding period that leads to the greatest annualized return for Supernus Pharmaceuticals, Inc., based on historical prices, is 1 week. Should Supernus Pharmaceuticals, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 167% could result.
